Anadolu Medical Center
Immunotherapy with Keytruda (Pembolizumab) in Istanbul typically costs from $4,500 to $6,900. Total expenses depend on the medication dosage, the number of treatment cycles, and diagnostic requirements like PET-CT scans. Patients save around 69% compared to the US, where this treatment costs $21,500 on average. Prices usually include oncologist consultations, blood tests, and airport transfers.
Bookimed Expert Insight: Istanbul concentrated the highest number of JCI-accredited oncology centers in Turkey, offering a structural advantage for complex immunotherapy. These facilities, such as Anadolu Medical Center, maintain direct affiliations with Johns Hopkins Hospital. This allows patients to access American-standard protocols. Choosing a multi-specialty hub like Medipol Mega lets patients combine treatment with advanced diagnostics like CyberKnife under one roof, often yielding better value than smaller clinics.
| Turkey | Austria | Spain | |
| Immunotherapy with Keytruda (Pembolizumab) | from $3,300 | from $15,000 | from $15,000 |
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.
Dr. Solak specializes in treating various cancers, including lung and gastrointestinal cancers, with extensive training at Hacettepe University Cancer Institute.
Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.
Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 international publications. She works at Anadolu Medical Center.
Medical oncologists in Istanbul are certified by the Turkish Ministry of Health. They often hold European Society for Medical Oncology (ESMO) board certifications. These specialists work in JCI-accredited facilities. They follow international NCCN guidelines to safely give immune checkpoint inhibitors like Keytruda.
Bookimed Expert Insight: Istanbul hospitals stand out for their high-volume specialization. Professor Yesim Yildirim at Anadolu Medical Center has over 20 years of experience and is ESMO certified. This institutional experience often leads to more personalized, biomarker-driven protocols. These protocols are tailored for complex stage 4 cases.
Patient Consensus: Patients stress the importance of confirming that the doctor is a medical oncologist, not a general practitioner. They report that bringing detailed pathology and biomarker results is vital. This information helps determine eligibility for Keytruda infusions.
Top medical centers in Istanbul offering Keytruda immunotherapy include Anadolu Medical Center, Memorial Şişli Hospital, and Istanbul Florence Nightingale Hospital. These JCI-accredited facilities provide pembrolizumab for several cancers, including lung, kidney, and gastrointestinal ones. Treatment is guided by biomarker testing and multidisciplinary tumor boards.
Bookimed Expert Insight: Anadolu Medical Center stands out because its oncologists, such as Prof. Dr. Yesim Yildirim, hold dual ESMO certifications and have trained at top centers in the UK and Israel. This deep expertise in tumor biology often results in more precise PD-L1 biomarker interpretation. Accurate interpretation is critical for Keytruda success.
Patient Consensus: Patients recommend contacting the medical oncology department directly to confirm drug availability. They report feeling more confident when clinics provide personal coordinators who help manage infusion-related fatigue and digestive side effects.
Istanbul oncology centers commonly treat non-small cell lung cancer, melanoma, and triple-negative breast cancer with Keytruda. These JCI-accredited clinics also use pembrolizumab for kidney, bladder, and head and neck cancers. Treatment typically needs a positive PD-L1 or MSI-H/dMMR biomarker status for best results.
Bookimed Expert Insight: Data from Istanbul facilities like Anadolu Medical Center shows a trend toward precision oncology. This trend is linked to Johns Hopkins affiliations. Surgeons often use Keytruda for late-stage cases. They also use it as perioperative therapy for triple-negative breast cancer. This earlier intervention aims to shrink tumors before surgery, potentially improving long-term surgical outcomes.
Patient Consensus: Patients emphasize that the three-week infusion cycle is manageable. But monitoring for side effects like fatigue or thyroid changes is vital. Patients appreciate the transparent approach in Istanbul. Biomarker testing directly dictates whether this immunotherapy will be effective.
International patients in Istanbul can get Keytruda through a medical tourism pathway at JCI-accredited facilities. The journey includes remote biomarker evaluation, VIP logistics, and outpatient infusions. The infusions are overseen by ESMO-certified oncologists. They work at major centers like Anadolu Medical Center or Hisar Hospital Intercontinental.
Bookimed Expert Insight: Many focus on the drug cost. But the real advantage in Istanbul is the Johns Hopkins or MD Anderson affiliations at centers like Anadolu or Hisar. These clinics use multidisciplinary boards. The boards make sure Keytruda is the best choice, not just an on-demand infusion.
Patient Consensus: Patients appreciate having dedicated interpreters who speak their language. They also report that while cumulative fatigue is common, the attentive staff makes the three-week infusion cycles manageable.
Turkish state health insurance (SSI/SGK) does not cover Keytruda for international patients or medical tourists in Istanbul. Local residents with active SGK contributions get partial coverage only for specific conditions like non-small cell lung cancer. For other diagnoses, they need to appeal through the courts to get reimbursed.
Bookimed Expert Insight: Patients often choose Istanbul because Keytruda costs are about 69% lower than the $21,500 US average. State insurance is not available for foreigners. However, private centers like Anadolu Medical Center provide direct access without the bureaucratic delays found in the state system, and this speed is vital for immunotherapy success.
Patient Consensus: Patients point out that infusions every three weeks can cause fatigue or digestive issues. Still, the attentive care in private Istanbul hospitals builds significant confidence. Patients suggest verifying specific diagnosis approval early to manage financial expectations.
International patients arrange Keytruda immunotherapy in Istanbul through a structured remote process. The workflow includes digital file intake, multidisciplinary tumor board reviews, and dedicated case management. Key steps include verifying PD-L1 biomarker status. Patients also get medical invitation letters for visas from JCI-accredited facilities like Anadolu Medical Center.
Bookimed Expert Insight: While immunotherapy is widely available, centers like Anadolu Medical Center stand out. Their unique advantage is a Johns Hopkins affiliation. Our data shows that patients who submit PD-L1 results remotely often save 2–3 days in Istanbul, since they bypass initial diagnostic delays. For children, specialized units are often a better fit. The 45-bed facility at Emsey Hospital, for example, is well-equipped for young patients needing Keytruda.
Patient Consensus: Patients emphasize that contacting the international desk early leads to a smooth transition. Patients recommend bringing both digital and paper copies of pathology reports. That way, they avoid redundant testing upon arrival.
Immunotherapy packages in Istanbul typically bundle logistical support like airport transfers and interpreters. However, medical diagnostics are usually separate. Initial consultations might be included. However, screenings like PET-CT scans and multi-cycle monitoring often require separate billing. This accommodates each patient’s weight and dosage needs.
Bookimed Expert Insight: Base costs for Keytruda infusions in Istanbul range from $4,500 to $6,900. However, the real value lies in the coordination. Leading centers like Anadolu Medical Center or Hisar Hospital Intercontinental provide dedicated case managers. These managers coordinate off-site hotel stays with the three-week infusion schedule. This prevents costly travel overlaps for international patients.
Patient Consensus: Patients appreciate the attentive care of Istanbul staff but emphasize requesting an itemized quote. Patients find that medication costs are clear. However, arranging separate logistics for diagnostic follow-ups requires careful planning.
Keytruda is covered by Turkey's social security institution (SGK) in Istanbul. However, reimbursement is strictly limited to specific cancer types and medical criteria. Coverage typically applies to non-small cell lung cancer and malignant melanoma. It often requires specific PD-L1 expression scores and prior treatment failures.
Bookimed Expert Insight: Social security has strict limits. But patients can save around 69% compared to US prices by choosing private clinics in Istanbul. Facilities like Anadolu Medical Center or Hisar Hospital bundle immunotherapy with VIP transfers and multi-lingual coordinators. This reduces the logistical burden when navigating complex reimbursement or legal appeals.
Patient Consensus: Patients emphasize the need to verify specific cancer indications with the hospital billing office. This should be done early on. Those undergoing treatment report high satisfaction with the attentive staff. This is despite common side effects like fatigue or digestive issues.
The total price for Keytruda immunotherapy in Istanbul depends on dosage requirements. Other factors are the number of prescribed cycles and hospital accreditation. Dosing schedules every 3 or 6 weeks directly affect the cost of this biological medication. This is the acquisition price at Joint Commission International-accredited facilities.
Bookimed Expert Insight: In Istanbul, a major cost difference is the pharmacy markup versus the infusion fee. The drug itself has a regulated base price. However, private clinics may charge much more for the infusion session. They may charge up to 17 times the cost of standard chemotherapy. Patients should ask for quotes that separate the drug cost from the oncology administration fee. This makes the price clear.
Patient Consensus: Patients often worry about digestive side effects and fatigue. However, they find confidence in the attentiveness of Turkish oncologists. Patients often stress one thing. Confirm whether quotes include hospital facility charges or just the medication vials.